Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11311
Peer-review started: June 28, 2021
First decision: July 26, 2021
Revised: July 27, 2021
Accepted: November 5, 2021
Article in press: November 5, 2021
Published online: December 26, 2021
Processing time: 178 Days and 6.3 Hours
Acute otitis media (AOM) is a common disease in children, affecting > 80% of children before the age of 3 years. AOM-associated sudden sensorineural hearing loss is a rare otological disorder, and the mechanism and treatment methods remain to be investigated.
If AOM-associated sudden hearing loss is not treated on time, it might cause permanent hearing loss. Therefore, early diagnosis and treatment of AOM-associated sudden hearing loss are important.
This study aimed to describe the audiological features of the patients with AOM-associated sudden hearing loss and evaluate the clinical efficacy of tympanostomy tube placement (TTP) and intratympanic methylprednisolone injection after failure of conventional medical therapy.
Patients with AOM-associated sudden hearing loss who visited the Department of Otolaryngology of Beijing Tsinghua Changgung Hospital between October 1, 2018 and June 1, 2020 and were ineffectively treated by conventional medical therapy were enrolled in this study. Basic data were collected, and pure-tone audiometry was performed to assess the audiological characteristics. Combination therapy with TTP and intratympanic methylprednisolone injection was given to the patients.
Mixed or sensorineural hearing loss was observed at high frequencies (2–4 kHz). All the patients in this study were cured after TTP and intratympanic methylprednisolone. After treatment, the average hearing threshold at affected frequencies was significantly lower than those in the pretreatment group and was similar to those in the healthy ears.
Our study indicated that AOM may rarely induce sudden sensorineural hearing loss, and high frequencies (2–4 kHz) are often involved. Combination therapy with TTP and intratympanic methylprednisolone injection may be a good salvage treatment modality for patients with AOM-associated sudden hearing loss after failure of conventional treatment.
Our study may bring more chances for recovery of patients with AOM-associated sudden hearing loss after failure of conventional treatment. However, our findings remain to be verified by well-designed studies with a large sample size.